Today’s inane image/video of the day:
References
On Stanford’s roll out [MIT Technology review]
On MGB’s roll out: article 1 [Boston Globe] and article 2 [GBH news]
If you’re curious about why I’ll be feeling better about my immunity to the virus after my second shot [I got the Pfizer vaccine, also known in the literature as the “BNT162b2 mRNA Covid-19 Vaccine”] here is the New England Journal of Medicine [NEJM] paper outlining the results of the phase 2/3 trials including 43,000+ individuals: “Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine.”